NCT02684760View on ClinicalTrials.gov

Bioavailability Study Of PF-06651600 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Healthy

Interventions

DRUG

PF-06651600

PF-06651600 will be administered as a tablet and extemporaneously prepared solution in each cohort.

Trial Locations (1)

1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT02684760 - Bioavailability Study Of PF-06651600 In Healthy Subjects | Biotech Hunter | Biotech Hunter